Fungal endophthalmitis in intravenous drug users injecting buprenorphine contaminated with oral Candida species

Craig A Aboltins, John R Daffy and Penny Allen
Med J Aust 2005; 182 (8): . || doi: 10.5694/j.1326-5377.2005.tb06764.x
Published online: 18 April 2005

Craig A Aboltins,* John R Daffy, Penny Allen

  • 1 St Vincent’s Hospital, Victoria Parade, Fitzroy, VIC 3065
  • 2 Royal Victorian Eye and Ear Hospital, East Melbourne, VIC.


We thank Dr Adam Jenney for his very helpful editing, Miss Rowena Fary for advice about buprenorphine dispensing and Dr C H Khong for assisting with clinical information about the patients.

  • 1. Essman TF, Flynn HF, Smiddy WE, et al. Treatment outcomes in a 10-year study of fungal endophthalmitis. Ophthalmic Surg Lasers 1997; 28: 185-194.
  • 2. Newton-John HF, Wise K, Looke DF. Role of the lemon in disseminated candidiasis of heroin abusers. Med J Aust 1984; 140: 780-781.
  • 3. Cassoux N, Bodaghi B, Lenoang P, Edel Y. Presumed ocular candidiasis in drug misusers after intravenous use of oral high dose buprenorphine (Subutex). Br J Ophthalmol 2002; 86: 940-941.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.